An important supplement entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward" has been published in Clinical Infectious Diseases to coincide with World Hepatitis Day.
 
The supplement was developed in collaboration with colleagues from the International Network on Hepatitis in Substance Users and focuses on original articles and review articles based on the 2nd International Symposium on Hepatitis Care in Substance Users which was held in Brussels, Belgium in 2011. This editorial provides further information on the supplement. 
 
The supplement also includes the first ever recommendations for the management of hepatitis C virus infection among people who inject drugs: 
 
Click here to see a press release, highlighting the impact of HCV treatment on reducing the burden of liver disease and further spread of HCV—especially among people who inject drugs, the highest prevalence population.